Loss of sexual desire
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial. To ensure impartial allocation and maintain a precise balance in the number of participants between the two intervention groups t
A&apos
and &apos
B&apos
within each block being entirely random. This method guarantees equal group sizes upon completion of recruitment. The principle of Allocation Concealment was strictly maintained throughout the study.
Sponsors
Programa de Pós Graduação em Tocoginecologia
Programa de Pós Graduação em Tocoginecologia
Eligibility
Sex/Gender
Female
Age
50 Years to 60 Years
Inclusion criteria
Inclusion criteria: Postmenopausal women aged 50 to 60 years; with 12 months of amenorrhea; a sexual partner; normal gynecological examinations within the past twelve months; and reduced sexual desire
Exclusion criteria
Exclusion criteria: Smokers; women with a history of chronic venous disease, cerebrovascular disease, cardiovascular disease, migraine with aura, hepatic diseases, elevated liver enzymes, malignant disease, or a partner with sexual dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An increase in total serum testosterone levels and in the free androgen index is expected after the use of transdermal testosterone, as measured by laboratory tests performed before the intervention and again after 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in the score of the questionnaire assessing sexual function, the Female Sexual Function Index, is expected after the use of transdermal testosterone, which will be administered before and 60 days after the intervention. | — |
Countries
Brazil
Contacts
Public ContactVivianne Ceccatto
Vivianne Parolin Ceccatto Andrade
Outcome results
None listed